Amniotic Fluid Cell-Derived Extracellular Matrix for Stem Cell Culture
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for culturing cells, particularly pluripotent stem cells, on plastic substrates are inadequate as they fail to replicate the native microenvironment, leading to suboptimal cell behavior and differentiation.
Innovation Solution
The use of an amniotic fluid cell-derived extracellular matrix (AFC-ECM) that is specifically designed to support the adhesion, isolation, expansion, and proliferation of pluripotent stem cells, including induced pluripotent stem cells (iPSCs) and embryonic stem cells (ES).
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Ease of manufacture
If cells are cultured on plastic substrates, then cell culture is simple and cost-effective, but the native microenvironment is not replicated leading to suboptimal cell behavior
Solution Approach 1:
The patent creates a synthetic extracellular matrix that copies the biochemical and biophysical properties of the native extracellular matrix. This includes replicating matrix composition, stiffness, and architectural features to provide authentic mechanical and biochemical cues to cultured cells, thereby maintaining cell behavior fidelity without requiring actual native tissue environments.
Solution Approach 2:
The patent systematically varies multiple parameters of the extracellular matrix including composition ratios, stiffness values, and architectural configurations to optimize cell culture outcomes. By adjusting these parameters, the system achieves both simplicity in culture methodology and high fidelity in cell behavior through controlled parameter optimization.
2Ease of manufacture
If individual matrix proteins are used to coat substrates, then the substrate is easier to prepare, but the complexity of the native microenvironment is disregarded
Solution Approach 1:
The patent employs composite materials that integrate multiple matrix proteins and biochemical cues into a unified substrate system. This composite approach captures the complexity and heterogeneity of the native microenvironment while maintaining practical ease of preparation through standardized composite formulations that can be applied systematically.
Solution Approach 2:
The patent develops a universal substrate system that incorporates multiple functional elements including adhesion sites, growth factor binding domains, and mechanical property controls within a single platform. This multi-functional substrate can support diverse cell types and experimental conditions while simplifying the preparation process through a standardized universal approach.
3Productivity
If cells are expanded in vitro from small biological samples, then large quantities of cells can be obtained, but the effects of in vitro culture on native cell characteristics are poorly understood
Solution Approach 1:
The patent utilizes the cells' own secreted extracellular matrix to create their culture substrate, forming a self-reinforcing system where cells produce the very environment they need to maintain their native characteristics. This self-service approach ensures that expanded cells remain in an authentic microenvironment that preserves their native properties throughout the expansion process.
Solution Approach 2:
The patent establishes an optimized extracellular matrix environment before cell expansion begins, pre-configuring the substrate with appropriate biochemical and biophysical properties. This preliminary preparation ensures that cells immediately encounter authentic microenvironmental cues upon plating, preventing drift from native characteristics during the subsequent expansion process.
Data Source
AI summary
Disclosed is a cell-derived extracellular matrix (ECM) derived in vitro from cells isolated from amniotic fluid, and methods of use for the isolation, maintenance, and proliferation of adherent cells including stem cells, as well as for the differentiation of stem cells.